BioAtla, Inc.
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conj…
Biotechnology
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared BioAtla, Inc. (BCAB) to it's peer group.
Peer Group
AVTE STTK RZLT FHTX IKNA KYMR PASG OLMA PMVP CCCC DSGN GLUE ERAS NRIX IPSC NAUT ACRV ANTX THRX
Compare Together
Loading...